Cargando…
Near-resolution of persistent idiopathic facial pain with low-dose lumbar intrathecal ziconotide: a case report
PURPOSE: Persistent idiopathic facial pain (PIFP) is a poorly defined and debilitating chronic pain state with a challenging and often inadequate treatment course. This is the first case report identifying the novel use of low-dose lumbar intrathecal ziconotide to successfully treat PIFP with nearly...
Autores principales: | Staub, Brandon P, Casini, Gianna P, Monaco, Edward A, Sekula, Raymond F, Emerick, Trent D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6413753/ https://www.ncbi.nlm.nih.gov/pubmed/30881103 http://dx.doi.org/10.2147/JPR.S193746 |
Ejemplares similares
-
Intrathecal Administration of Ziconotide as a Potential Treatment for Chronic Migraines
por: Holden, Ryan, et al.
Publicado: (2022) -
Resolution of chronic migraine headaches with intrathecal ziconotide: a case report
por: Narain, Sachin, et al.
Publicado: (2015) -
Intrathecal pain management with ziconotide: Time for consensus?
por: Matis, Georgios, et al.
Publicado: (2021) -
Safety and efficacy of intrathecal ziconotide in the management of severe chronic pain
por: Smith, Howard S, et al.
Publicado: (2009) -
Intrathecal Ziconotide: Dosing and Administration Strategies in Patients With Refractory Chronic Pain
por: McDowell, Gladstone C., et al.
Publicado: (2016)